Pfizerv0.1.1

Analysts can use the skill to gather up-to-date information on Pfizer's drug portfolio, pipeline, and clinical trials. This supports market research and competitive analysis against other pharma companies like Moderna or Merck.

Investors can query Pfizer's stock price, dividends, earnings reports, and revenue to make informed decisions. The skill provides quick access to financial data and company fundamentals.

Doctors and pharmacists can learn about Pfizer's drugs, their indications, and comparisons (e.g., COVID vaccines). This helps in patient counseling and staying current with new approvals.

Writers can source detailed information on Pfizer's products and pipeline for articles, reports, or content creation. The skill offers reliable data from official sources.

Patients or caregivers can get accessible explanations of Pfizer drugs, their uses, and side effects. This supports informed health decisions and adherence to treatments.

Basic queries about drugs and pipeline are free, while detailed financial analytics and real-time stock data require a subscription. This attracts both casual users and serious investors.

Provide API access to third-party applications (e.g., investment platforms, medical databases) for a usage-based fee. This scales the skill's reach into existing ecosystems.

Offer free public access with optional sponsored content from partner companies (e.g., clinical trial recruiters). Advertisements or promoted results generate revenue while keeping info free.